Huaxia Wealth Management Fixed Income Debt-Type Closed-End Investment No. 1362 will be issued starting March 30, with the A Share performance benchmark of 2.75%-3.05%.

LightningPacketLoss · 2026-03-30T08:30:25+00:00

Huaxia Wealth Management has launched Fixed Income Debt-type Wealth Management Product No. 1362, with a fundraising period from March 30, 2026, to April 8, 2026. The minimum subscription amount is 1 yuan, with an issuance scale lower limit of 50 million yuan. The term is 740 days, with a medium-low risk level. The annualized performance benchmark for Share A is 2.75%-3.05%, and for Share B is 2.70%-3.00%. Product details should refer to the relevant sales documents.

LightningPacketLoss

2026-03-30 08:30:25

Abstract generation in progress

On March 30, according to Huaxia Wealth Management, the fundraising period for the fixed income debt closed-end wealth management product No. 1362 issued by the company is from March 30, 2026, to April 8, 2026 (inclusive). The minimum subscription amount is 1 yuan, and the lower limit of the issuance scale is 50 million yuan. The investment nature of the product is fixed income, and the product is classified as PR2 (medium-low risk), with a term of 740 days. The performance benchmark for Class A shares is 2.75%-3.05% (annualized); the performance benchmark for Class B shares is 2.70%-3.00% (annualized).

Note: The performance benchmark is not the expected yield, does not represent the future performance and actual returns of the product, and does not constitute a commitment to the product’s returns.

The information about the above wealth management products is for reference only, and specific details should be based on the “Product Disclosure” and other sales documents. This article does not constitute any investment advice, and investors operate at their own risk based on this information.

(Huaxia Wealth Management)

(Editor: Qian Xiaorui)

Keywords:

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.